Erasca, Inc. (ERAS)
14.25
-0.27
(-1.86%)
USD |
NASDAQ |
Sep 25, 16:00
14.26
+0.01
(+0.07%)
After-Hours: 19:59
Erasca Cash and Short Term Investments (Annual) : 276.08M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 276.08M |
| December 31, 2024 | 298.31M |
| December 31, 2023 | 312.35M |
| December 31, 2022 | 435.62M |
| Date | Value |
|---|---|
| December 31, 2021 | 414.48M |
| December 31, 2020 | 118.70M |
| December 31, 2019 | 50.37M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Revolution Medicines, Inc. | 2.026B |
| Twist Bioscience Corp. | 232.43M |
| Tango Therapeutics, Inc. | 343.57M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |